Payment overview · 2025
General Payments
$285.71
2 reported records · 2 companies
Healthcare provider profile · identity verified
Kamal Khalafi, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · BEACHWOOD, OH · NPI 1992791263
Verified facts
What the public records show
CMS Open Payments records show Kamal Khalafi, M.D. received $285.71 in general payments during 2025 across 2 reported records.
Olympus America Inc. accounted for 52.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 45 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Olympus America Inc. | Unresolved — no canonical attribution shown | $150.71 | 52.8% | 1 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $135.00 | 47.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $285.71 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| iTIND System Normalized: itind system |
Device | Olympus America Inc. | $150.71 | 1 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $135.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
45 | 12 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1088 | 232 |
| Amlodipine Besylate | Amlodipine Besylate | 837 | 213 |
| Furosemide | Furosemide | 573 | 134 |
| Eliquis | Apixaban | 445 | 66 |
| Losartan Potassium | Losartan Potassium | 444 | 118 |
| Gabapentin | Gabapentin | 427 | 88 |
| Metformin Hcl | Metformin Hcl | 416 | 87 |
| Metoprolol Tartrate | Metoprolol Tartrate | 407 | 73 |
| Potassium Chloride | Potassium Chloride | 390 | 73 |
| Metoprolol Succinate | Metoprolol Succinate | 385 | 100 |
| Levothyroxine Sodium | Levothyroxine Sodium | 361 | 76 |
| Omeprazole | Omeprazole | 344 | 72 |
| Lisinopril | Lisinopril | 339 | 74 |
| Pantoprazole Sodium | Pantoprazole Sodium | 317 | 70 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 293 | 74 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 276 | 91 |
| Clopidogrel | Clopidogrel Bisulfate | 234 | 52 |
| Carvedilol | Carvedilol | 228 | 55 |
| Mirtazapine | Mirtazapine | 213 | 53 |
| Escitalopram Oxalate | Escitalopram Oxalate | 203 | 26 |
| Jardiance | Empagliflozin | 201 | 33 |
| Donepezil Hcl | Donepezil Hcl | 188 | 35 |
| Tamsulosin Hcl | Tamsulosin Hcl | 183 | 46 |
| Sertraline Hcl | Sertraline Hcl | 178 | 38 |
| Hydralazine Hcl | Hydralazine Hcl | 176 | 50 |
| Famotidine | Famotidine | 160 | 35 |
| Januvia | Sitagliptin Phosphate | 136 | 18 |
| Spironolactone | Spironolactone | 133 | 29 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 126 | 32 |
| Trazodone Hcl | Trazodone Hcl | 125 | 28 |
| Quetiapine Fumarate | Quetiapine Fumarate | 118 | 15 |
| Montelukast Sodium | Montelukast Sodium | 117 | 20 |
| Allopurinol | Allopurinol | 116 | 35 |
| Hydrochlorothiazide | Hydrochlorothiazide | 114 | 34 |
| Pravastatin Sodium | Pravastatin Sodium | 113 | 24 |
| Memantine Hcl | Memantine Hcl | 110 | 18 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 102 | 33 |
| Divalproex Sodium | Divalproex Sodium | 99 | 17 |
| Xarelto | Rivaroxaban | 99 | 17 |
| Torsemide | Torsemide | 92 | 21 |
| Fluticasone Propionate | Fluticasone Propionate | 89 | 34 |
| Prednisone | Prednisone | 89 | 53 |
| Clonidine Hcl | Clonidine Hcl | 86 | 21 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 85 | 24 |
| Simvastatin | Simvastatin | 85 | 22 |
| Buspirone Hcl | Buspirone Hcl | 84 | 12 |
| Alendronate Sodium | Alendronate Sodium | 82 | 21 |
| Entresto | Sacubitril/Valsartan | 81 | 13 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 80 | 21 |
| Meloxicam | Meloxicam | 75 | 32 |
| Glipizide | Glipizide | 73 | 14 |
| Warfarin Sodium | Warfarin Sodium | 69 | 19 |
| Amiodarone Hcl | Amiodarone Hcl | 67 | 16 |
| Linzess | Linaclotide | 64 | 21 |
| Levetiracetam | Levetiracetam | 63 | suppressed |
| Baclofen | Baclofen | 62 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 62 | 20 |
| Glipizide Er | Glipizide | 61 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 61 | 14 |
| Latanoprost | Latanoprost | 60 | 14 |
| Glimepiride | Glimepiride | 59 | 25 |
| Meclizine Hcl | Meclizine Hcl | 59 | 14 |
| Olanzapine | Olanzapine | 59 | 11 |
| Finasteride | Finasteride | 55 | 14 |
| Digoxin | Digoxin | 54 | 14 |
| Ezetimibe | Ezetimibe | 52 | suppressed |
| Ozempic | Semaglutide | 52 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 52 | 17 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 51 | 16 |
| Atenolol | Atenolol | 50 | 12 |
| Ammonium Lactate | Ammonium Lactate | 49 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 49 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 48 | 20 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 47 | suppressed |
| Trulicity | Dulaglutide | 46 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 45 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 44 | 21 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 43 | 15 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 40 | 14 |
| Ibuprofen | Ibuprofen | 40 | 15 |
| Tradjenta | Linagliptin | 39 | suppressed |
| Aripiprazole | Aripiprazole | 38 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 38 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 37 | 12 |
| Nystatin | Nystatin | 36 | 24 |
| Amoxicillin | Amoxicillin | 35 | 20 |
| Kerendia | Finerenone | 35 | suppressed |
| Ketoconazole | Ketoconazole | 34 | suppressed |
| Lubiprostone | Lubiprostone | 33 | suppressed |
| Myrbetriq | Mirabegron | 32 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 31 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 30 | suppressed |
| Hydrocortisone | Hydrocortisone | 30 | suppressed |
| Klor-Con M20 | Potassium Chloride | 30 | 13 |
| Oxycodone Hcl | Oxycodone Hcl | 30 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 30 | suppressed |
| Clotrimazole | Clotrimazole | 29 | suppressed |
| Klor-Con M10 | Potassium Chloride | 29 | suppressed |
| Topiramate | Topiramate | 29 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 28 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 28 | suppressed |
| Lacosamide | Lacosamide | 28 | suppressed |
| Lidocaine | Lidocaine | 28 | suppressed |
| Methocarbamol | Methocarbamol | 28 | suppressed |
| Trospium Chloride | Trospium Chloride | 27 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 26 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 25 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 25 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 25 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Haloperidol | Haloperidol | 24 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 24 | 12 |
| Sulfasalazine | Sulfasalazine | 24 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 23 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 23 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 23 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 23 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 22 | suppressed |
| Cephalexin | Cephalexin | 22 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 22 | 11 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 22 | 21 |
| Lithium Carbonate | Lithium Carbonate | 22 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Naproxen | Naproxen | 22 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 22 | 14 |
| Pregabalin | Pregabalin | 22 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 22 | 14 |
| Diltiazem Hcl | Diltiazem Hcl | 21 | suppressed |
| Dofetilide | Dofetilide | 21 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 21 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Methotrexate | Methotrexate Sodium | 21 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 21 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 20 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 20 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 20 | suppressed |
| Lamotrigine | Lamotrigine | 20 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 20 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 20 | suppressed |
| Cilostazol | Cilostazol | 19 | suppressed |
| Colchicine | Colchicine | 19 | suppressed |
| Fluconazole | Fluconazole | 19 | 13 |
| Naltrexone Hcl | Naltrexone Hcl | 19 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 19 | suppressed |
| Valsartan | Valsartan | 19 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 18 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | suppressed |
| Letrozole | Letrozole | 18 | suppressed |
| Nifedipine Er | Nifedipine | 18 | suppressed |
| Nitroglycerin | Nitroglycerin | 18 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 18 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 18 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 17 | 17 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 17 | suppressed |
| Risperidone | Risperidone | 17 | suppressed |
| Telmisartan | Telmisartan | 17 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 17 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 16 | suppressed |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 16 | suppressed |
| Minoxidil | Minoxidil | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Creon | Lipase/Protease/Amylase | 14 | suppressed |
| Epinephrine | Epinephrine | 14 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 14 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 14 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 13 | suppressed |
| Insulin Lispro | Insulin Lispro | 13 | suppressed |
| M-Natal Plus | Pnv,calcium 72/Iron/Folic Acid | 13 | suppressed |
| Methimazole | Methimazole | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Pro Comfort Alcohol Pads | Alcohol Antiseptic Pads | 13 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 13 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 13 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Dexamethasone | Dexamethasone | 12 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 12 | 12 |
| Easy Touch Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Estradiol | Estradiol | 12 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 12 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 12 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 12 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 12 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 11 | suppressed |
| Cefdinir | Cefdinir | 11 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $285.71 · 2 records | Olympus America Inc. | AIRSUPRA, iTIND System | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error